Ftse Mib
34.256,74
-0,35%
DAX
18.500,55
-0,54%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.212,47
-2,53%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX BioPharmX Corporation (BPMX) BioPharmX Corporation (BPMX) Notizie

BPMX

BioPharmX (BPMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX
DataOraFonteTitoloSimboloCompagnia
10/12/201522:10PR Newswire (US)BioPharmX Corporation Closes Direct InvestmentAMEX:BPMXBioPharmX Corporation
10/11/201514:00PR Newswire (US)BioPharmX Corporation to Offer Violet Iodine Supplement in over 3,000 General Nutrition Center (GNC) StoresAMEX:BPMXBioPharmX Corporation
04/11/201514:00PR Newswire (US)Study Shows BioPharmX Formulation Offers More Effective Acne Treatment by Targeted Delivery of MinocyclineAMEX:BPMXBioPharmX Corporation
29/10/201513:00PR Newswire (US)BioPharmX Corporation Names AnnaMarie Daniels Executive Vice President of Clinical and Regulatory AffairsAMEX:BPMXBioPharmX Corporation
14/10/201514:00PR Newswire (US)Study Shows Novel BioPharmX Formulation Promises Breakthrough in Acne TreatmentAMEX:BPMXBioPharmX Corporation
13/10/201518:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
29/09/201515:00PR Newswire (US)BioPharmX Corporation Expands Management Team to Support Growth and Market ExpansionAMEX:BPMXBioPharmX Corporation
22/09/201513:30PR Newswire (US)Survey Shows Most U.S. Women Suffer from Premenstrual Breast DiscomfortAMEX:BPMXBioPharmX Corporation
14/09/201523:21Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
14/09/201522:47Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
14/09/201522:05PR Newswire (US)BioPharmX Corporation Reports Second Quarter ResultsAMEX:BPMXBioPharmX Corporation
09/09/201514:00PR Newswire (US)BioPharmX Corporation to Release Second Quarter 2016 Financial ResultsAMEX:BPMXBioPharmX Corporation
02/09/201514:00PR Newswire (US)BioPharmX Corporation To Present at Rodman & Renshaw 17th Annual Global Investment ConferenceAMEX:BPMXBioPharmX Corporation
12/08/201519:03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BPMXBioPharmX Corporation
12/08/201514:00PR Newswire (US)Seasoned Silicon Valley Financial Executive Joins BioPharmX Corporation As Chief Financial OfficerAMEX:BPMXBioPharmX Corporation
28/07/201514:00PR Newswire (US)BioPharmX Corporation Launches Grocery Store Distribution of Violet® Iodine at Kroger SubsidiaryAMEX:BPMXBioPharmX Corporation
17/07/201514:00PR Newswire (US)BioPharmX Corporation Launches #HugsShouldntHurt Social Media CampaignAMEX:BPMXBioPharmX Corporation
16/07/201513:00PR Newswire (US)OTC Markets Group Announces Second Quarter 2015 Index Performance and RebalancingAMEX:BPMXBioPharmX Corporation
13/07/201514:30PR Newswire (US)BioPharmX To Ring New York Stock Exchange Opening Bell To Celebrate Its Listing On NYSE MKTAMEX:BPMXBioPharmX Corporation
08/07/201515:22PR Newswire (US)Cleavage vs. Cover-up: New Study Sponsored By Violet® iodine Reveals 73 percent of American Women Aren't Looking to Show-off...AMEX:BPMXBioPharmX Corporation
02/07/201521:47Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)AMEX:BPMXBioPharmX Corporation
01/07/201513:00PR Newswire (US)BioPharmX Corporation Closes Underwritten Public Offering of Common StockAMEX:BPMXBioPharmX Corporation
29/06/201516:10Edgar (US Regulatory)Confidential Treatment Order (ct Order)AMEX:BPMXBioPharmX Corporation
25/06/201522:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)AMEX:BPMXBioPharmX Corporation
25/06/201512:06Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)AMEX:BPMXBioPharmX Corporation
25/06/201512:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
22/06/201512:12Edgar (US Regulatory)Securities Registration Statement (s-1/a)AMEX:BPMXBioPharmX Corporation
21/04/201522:50Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
20/04/201523:27Edgar (US Regulatory)Annual Transition Report (10-kt)AMEX:BPMXBioPharmX Corporation
09/04/201523:37PR Newswire (US)BioPharmX Corporation Files Registration Statement For Proposed Public OfferingAMEX:BPMXBioPharmX Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX

La tua Cronologia

NYSE
NM
Navios Maritime
LSE
92SV
Sg Issuer 29
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network